Corvidia Therapeutics

Novo Nordisk A/S has opened its bulging wallet to acquire Germany's Cardior Pharmaceuticals GmbH , boosting its cardiovascular pipeline through a deal worth up to €1.03bn. The Hannover-based biotech

With a star pipeline candidate entering Phase III clinical trials for the treatment for ulcerative colitis, Abivax S.A. is in the midst of a corporate rework to be able to secure funding and ultimat

With a stellar career in the pharmaceutical industry, including CEO roles for the last 12 years, Marc de Garidel could have been forgiven for putting his feet up for a while rather than taking the hel

Roche Exploring New Areas Of BD Roche Holding AG global head of pharma partnering James Sabry told Scrip the company is exploring business development in new therapeutic areas outside of the ones